Reducing liver fat by low carbohydrate caloric restriction targets hepatic glucose production in non-diabetic obese adults with non-alcoholic fatty liver disease

Journal of Clinical Medicine

Volumn 3, Issue 3, 2014, Pages 1050-1063

  Yu, Haoyong ^a   Jia, Weiping ^a   Guo, Zengkui ^b  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b MAYO CLINIC   (United States)

Author keywords

Caloric restriction; Glucose disposal; Hepatic glucose production; Liver fat; Obesity

Indexed keywords

CARBOHYDRATE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; CALORIC INTAKE; CALORIC RESTRICTION; FATTY LIVER; FEMALE; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HUMAN; HUMAN EXPERIMENT; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; MALE; MASS FRAGMENTOGRAPHY; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PROTON NUCLEAR MAGNETIC RESONANCE; WAIST CIRCUMFERENCE;

EID: 85048810544     PISSN: None     EISSN: 20770383     Source Type: Journal    
DOI: 10.3390/jcm3031050     Document Type: Article

References (26)

1. Moller, D.E. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 2001, 414, 821-827.
2. Unger, R.H. Lipotoxic diseases. Annu. Rev. Med. 2002, 53, 319-336.
3. Friedman, J. Fat in all the wrong places. Nature 2002, 415, 268-269.
4. Brunt, E.M.; Janney, C.G.; Di Bisceglie, A.M.; Neuschwander-Tetri, B.A.; Bacon, B.R. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 1999, 94, 2467-2474.
5. Matteoni, C.A.; Younossi, Z.M.; Gramlich, T.; Boparai, N.; Liu, Y.C.; McCullough, A.J. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 1999, 116, 1413-1419.
6. Hurjui, D.M.; Niţă, O.; Graur, L.I.; Mihalache, L.; Popescu, D.S.; Graur, M. The central role of the non-alcoholic fatty liver disease in metabolic syndrome. Rev. Med. Chir. Soc. Med. Nat. Iasi 2012, 116, 425-431.
7. Larson-Meyer, D.E.; Newcomer, B.R.; Heilbronn, L.K.; Volaufova, J.; Smith, S.R.; Alfonso, A.J.; Lefevre, M.; Rood, J.C.; Williamson, D.A.; Ravussin, E., et al. Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. Obesity 2008, 16, 1355-1362.
8. Völgyi, E.; Tylavsky, F.A.; Lyytikäinen, A.; Suominen, H.; Alén, M.; Cheng, S. Assessing body composition with DXA and bioimpedance: Effects of obesity, physical activity, and age. Obesity 2008, 16, 700-705.
9. Chowdhury, B.; Sjostrom, L.; Alpsten, M.; Kostanty, J.; Kvist, H.; Lofgren, R. A multi-compartment body composition technique based on computerized tomography. Int. J. Obes. 1994, 18, 219-234.
10. Hoenig, M.R.; Cowin, G.; Buckley, R.; McHenery, C.; Coulthard, A. Liver fat percent is associated with metabolic risk factors and the metabolic syndrome in a high-risk vascular cohort. Nutr. Metab. 2010, 7, doi:10.1186/1743-7075-7-50.
11. Xia, M.F.; Yan, H.M.; Lin, H.D.; Bian, H.; Pan, B.S.; Yao, X.Z.; Li, R.K.; Zeng, M.S.; Gao, X. Elevation of liver enzymes within the normal limits and metabolic syndrome. Clin. Exp. Pharmacol. Physiol. 2011, 38, 373-379.
12. Szczepaniak, L.S.; Nurenberg, P.; Leonard, D.; Browning, J.D.; Reingold, J.S.; Grundy, S.; Hobbs, H.H.; Dobbins, R.L. Magnetic resonance spectroscopy to measure hepatic triglyceride content: Prevalence of hepatic steatosis in the general population. Am. J. Physiol. 2005, 288, doi:10.1152/ajpendo.00064.2004.
13. Yu, H.; Zhou, D.; Jia, W.; Guo, Z.K. Locating the source of hyperglycemia: Liver versus muscle. J. Diabetes 2012, 4, 30-36.
14. Cohen, J.C.; Horton, J.D.; Hobbs, H.H. Human fatty liver disease: Old questions and new insights. Science 2011, 332, 1519-1523.
15. Kirk, E.; Reeds, D.N.; Finck, B.N.; Mayurranjan, S.M.; Patterson, B.W.; Klein, S. Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology 2009, 136, 1552-1560.
16. Hellerstein, M.K.; Christiansen, M.; Kaempfer, S.; Kletke, C.; Wu, K.; Reid, J.S.; Mulligan, K.; Hellerstein, N.S.; Shackleton, C.H. Measurement of de novo hepatic lipogenesis in humans using stable isotopes. J. Clin. Invest. 1991, 87, 1841-1852.
17. Aarsland, A.; Wolfe, R.R. Hepatic secretion of VLDL fatty acids during stimulated lipogenesis in men. J. Lipid Res. 1998, 39, 1280-1286.
18. Guo, Z.K.; Cella, L.K.; Baum, C.; Ravussin, E.; Schoeller, D.A. De novo lipogenesis in adipose tissue of lean and obese women: Application of deuterated water and isotope ratio mass spectrometry. Int. J. Obes. Relat. Metab. Disord. 2000, 24, 932-937.
19. Timlin, M.T.; Parks, E.J. Temporal pattern of de novo lipogenesis in the postprandial state in healthy men. Am. J. Clin. Nutr. 2005, 81, 35-42.
20. Donnelly, K.L.; Smith, C.I.; Schwarzenberg, S.J.; Jessurun, J.; Boldt, M.D.; Parks, E.J. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 2005, 115, 1343-1351.
21. Guo, Z.; Jensen, M.D. Blood glycerol is an important precursor for intramuscular triacylglycerol synthesis. J. Biol. Chem. 1999, 274, 23702-23706.
22. Choi, S.S.; Diehl, A.M. Hepatic triglyceride synthesis and nonalcoholic fatty liver disease. Curr. Opin. Lipidol. 2008, 19, 295-300.
23. Sunny, N.E.; Parks, E.J.; Browning, J.D.; Burgess, S.C. Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab. 2011, 14, 804-810.
24. Klein, S.; Mittendorfer, B.; Eagon, J.C.; Patterson, B.; Grant, L.; Feirt, N.; Seki, E.; Brenner, D.; Korenblat, K.; McCrea, J. Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease. Gastroenterology 2006, 130, 1564-1572.
25. Boily, G.; Seifert, E.L.; Bevilacqua, L.; He, X.H.; Sabourin, G.; Estey, C.; Moffat, C.; Crawford, S.; Saliba, S.; Jardine, K., et al. SirT1 regulates energy metabolism and response to caloric restriction in mice. PLoS One 2008, 3, e1759.
26. Park, Y.J.; Lim, J.H.; Kwon, E.R.; Kim, H.K.; Jung, M.C.; Seol, K.H.; Noh, W.Y.; Kim, N.E. Development and validation of a simple index system to predict nonalcoholic fatty liver disease. Korean J. Hepatol. 2011, 17, 19-26.